Search Results - "Armario, P."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    [OP.4A.10] RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY by De La Sierra, A, Pareja, J, Armario, P, Barrera, A, Sans, L, Vazquez, S, Oliveras, A

    Published in Journal of hypertension (01-09-2016)
    “…OBJECTIVE:We have previously reported that spironolactone (S) was superior to renal denervation (RD) in reducing 24-hour blood pressure in resistant…”
    Get full text
    Journal Article
  7. 7

    [OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS by Oliveras, A, Armario, P, Sans, L, Clarà, A, Vázquez, S, Molina, L.L, Pascual, J, De La Sierra, A

    Published in Journal of hypertension (01-09-2016)
    “…OBJECTIVE:Both renal denervation (RDN) and spironolactone have been proposed for the treatment of resistant hypertension (RH). However, they have not been…”
    Get full text
    Journal Article
  8. 8

    2021 Spanish Society of Hypertension position statement about telemedicine by Gijón-Conde, T., Rubio, E., Gorostidi, M., Vinyoles, E., Armario, P., Rodilla, E., Segura, J., Divisón-Garrote, J.A., García-Donaire, J.A., Molinero, A., Ruilope, L.M.

    Published in Hipertensión y riesgo vascular (01-10-2021)
    “…The pandemic caused by coronavirus SARS-CoV-2 (COVID-19) has forced, in many cases, to replace face-to-face consultation with the telematic consultation, in…”
    Get full text
    Journal Article
  9. 9

    Cancer and cardiovascular risk by Blanch Gracia, P, Mena Sebastià, E, Villanueva Vázquez, R, Tirapu Sola, L, Losa Gaspà, F, Freixa-Pamias, R, Armario, P

    Published in Hipertension y riesgo vascular (01-07-2021)
    “…Cancer survivors have lower long-term survival, in part due to increased cardiovascular disease (CVD). Up to 30% of the deaths of patients with cancer may be…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Malignant arterial hypertension (HTAM) with severe systolic dysfunction of the reversible left ventricle by Cortés Fernández, M S, Monteys Montblanch, J P, Castellanos Lleuger, P, Armario, P

    Published in Hipertension y riesgo vascular (01-04-2020)
    “…Malignant arterial hypertension is still present in current clinical care despite the fact that for more than three decades we have had a wide range of…”
    Get more information
    Journal Article
  12. 12

    Urinary albumin excretion is associated with true resistant hypertension by Oliveras, A, Armario, P, Hernández-del Rey, R, Arroyo, J A, Poch, E, Larrousse, M, Roca-Cusachs, À, de la Sierra, A

    Published in Journal of human hypertension (01-01-2010)
    “…Resistant (or refractory) hypertension (RH) is a clinical diagnosis based on blood pressure (BP) office measurements. About one third of subjects with…”
    Get full text
    Journal Article
  13. 13

    Hipertensión arterial resistente by Armario, P, Oliveras, A, de la Sierra, A

    Published in Hipertensión y riesgo vascular (01-04-2014)
    “…Resumen La hipertensión arterial resistente (HTAR) tiene una prevalencia del 10-12%. La monitorización ambulatoria de la presión arterial (MAPA) es fundamental…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Papel de la MAPA en el manejo de la hipertensión arterial resistente by Armario, P

    Published in Hipertensión y riesgo vascular (2010)
    “…Resumen La hipertensión arterial (HTA) se define como refractaria o resistente al tratamiento antihipertensivo cuando no se obtiene un adecuado control de la…”
    Get full text
    Journal Article
  20. 20

    Crisis hipertensiva y alteración brusca de la visión en el paciente joven by Cortés Fernández, M.S, Martín-Castillejos, C, Armario, P

    Published in Hipertensión y riesgo vascular (01-07-2016)
    “…Resumen La alteración brusca de la visión es una urgencia médica en la cual se deben descartar entidades como la vasculitis sistémica, el ictus isquémico y la…”
    Get full text
    Journal Article